Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 2.23
- Piotroski Score 7.00
- Grade Buy
- Symbol (INVA)
- Company Innoviva, Inc.
- Price $19.05
- Changes Percentage (-1.85%)
- Change -$0.36
- Day Low $18.83
- Day High $19.58
- Year High $19.85
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a long-acting muscarinic antagonist (LAMA), umeclidinium bromide (UMEC), with a LABA, and VI; and TRELEGY ELLIPTA, a once-daily combination medicine consisting of an ICS, LAMA, and LABA. Innoviva, Inc. has a strategic partnership with Sarissa Capital Management LP. The company has long-acting beta2 agonist (LABA) collaboration agreement with Glaxo Group Limited to develop and commercialize once-daily products for the treatment of chronic obstructive pulmonary disease and asthma. The company was formerly known as Theravance, Inc. and changed its name to Innoviva, Inc. in January 2016. Innoviva, Inc. was incorporated in 1996 and is headquartered in Burlingame, California.
- Last Earnings 07/30/2015
- Ex-Dividend for 5/16 Dividend 09/08/2015
- Dividend Payable 09/30/2015
- Today N/A
- Next Earnings (Estimated) 10/30/2024
- Fiscal Year End N/A
- Average Stock Price Target $13.00
- High Stock Price Target $13.00
- Low Stock Price Target $13.00
- Potential Upside/Downside N/A
- Consensus Rating Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) $2.24
- Trailing P/E Ratio 7.21
- Forward P/E Ratio 7.21
- P/E Growth 7.21
- Net Income $179.72 M
Income Statement
Quarterly
Annual
Latest News of INVA
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Invasive, fast-growing plant threatens homes, property prices as it...
The Japanese knotweed, an invasive plant species in the US, spreads rapidly and is difficult to eradicate. It poses a threat to properties and can devalue homes. Various methods exist to control it, i...
By New York Post | 1 day ago -
Hedge fund turned to a wargame to plan for a Chinese invasion of Taiwan
Business Insider subscribers can access a wargame scenario where a British hedge fund navigates a Chinese invasion of Taiwan, showcasing the impact on global economy and investment strategies. This te...
By Business Insider | 1 day ago -
In The Chaos Of the Kursk Invasion, Fast-Moving Ukrainians Captured Seven Russian Tanks -- And Gave Up 10 Infantry Vehicles
Ukraine's advance in Russia's Kursk Oblast has slowed due to stretched supply lines. The front line is becoming fortified and static, with exchanges of captured vehicles. The situation remains fluid, ...
By Forbes | 1 week ago
